Le Lézard8m
MRVI INVESTOR ALERT: Maravai LifeSciences Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Maravai LifeSciences Holdings, Inc. securities between August 7, 2024 and February 24, 2025, inclusive (the ...
Investor Alert: Robbins LLP Informs Investors Of The Maravai Lifesciences Holdings, Inc. Class Action Lawsuit
On February 25, 2025, Maravai revealed it identified an error in revenue recognition and "a material weakness in its internal controls over revenue recognition. On this news, the price of the ...
Maravai LifeSciences Sees Unusually High Options Volume (NASDAQ:MRVI)
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI – Get Free Report) was the recipient of some unusual options trading on Wednesday. Traders bought 1,002 put options on the stock. This represents an ...
Maravai LifeSciences (NASDAQ:MRVI) Hits New 12-Month Low Following Analyst Downgrade
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI – Get Free Report)’s share price hit a new 52-week low on Tuesday after Bank of America lowered their price target on the stock from $9.00 to $8.00.
Business Wire13h
MRVI ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of Maravai Lifesciences Holdings, Inc. Investors
The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Southern District of Calif ...
TMCnet23h
Rosen Law Firm Urges Maravai Lifesciences Holdings, Inc. (NASDAQ: MRVI) Stockholders to Contact the Firm for Information About Their Rights
The Allegations: Rosen Law Firm is Investigating the Allegations that Maravai Lifesciences Holdings, Inc. (NASDAQ: MRVI) Misled Investors Regarding its Business Operations.
Bronstein, Gewirtz & Grossman, LLC Encourages Maravai LifeSciences Holdings, Inc. (MRVI) Investors to Inquire about Securities Investigation
NEW YORK CITY, NY / ACCESS Newswire / March 5, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on ...
Craig-Hallum Keeps Their Buy Rating on Maravai Lifesciences Holdings (MRVI)
In a report released today, Matt Hewitt from Craig-Hallum maintained a Buy rating on Maravai Lifesciences Holdings (MRVI – Research Report).
Lawyer Monthly1d
The Law Offices of Frank R. Cruz Files Lawsuit Against Maravai LifeSciences Holdings, Inc.
The Law Offices of Frank R. Cruz files class action lawsuit against Maravai LifeSciences for securities fraud over revenue ...
Le Lézard1d
MRVI Investors Have Opportunity to Lead Maravai LifeSciences Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Maravai LifeSciences Holdings, Inc. ("Maravai" or "the Company") violations of § ...
TMCnet1d
MRVI Class Action Notice: Glancy Prongay & Murray LLP Files Securities Fraud Lawsuit on Behalf of Maravai LifeSciences Holdings, Inc. Investors
Glancy Prongay & Murray LLP ("GPM"), announces that it has filed a class action lawsuit in the United States District Court for the Southern District of California, captioned Nelson v. Maravai ...
Maravai LifeSciences Holdings, Inc. (MRVI) Acquires Officinae Bio to Enhance AI-Driven mRNA Development
We recently compiled a list of the 18 AI News and Ratings Making Waves on Wall Street. In this article, we are going to take ...